09/04/2014 - 22:28
Results of TOPCAT, one of the most talked about heart failure trials in recent years, have been published. There were no obvious surprises: Spironolactone is no more beneficial than placebo for...
Field of Interest: Cardiology
Categories:
News Feed: Internal Medicine News - Cardiology